Incannex Healthcare Quarterly Activities Report and Appendix 4C Cash Flow Statement
- Wednesday, July 27, 2022, 7:04
- Finance
- Add a comment
MELBOURNE, Australia, July 27, 2022 /PRNewswire/ — Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is pleased to provide its quarterly activities report and appendix 4C for the period ended 30 June…
About the Author
adminasapcorp has written 39023 stories on this site.